Immune Repertoire Sequencing Market was valued at USD 116.2 million in 2020 and is expected to reach 180 million by 2027 at a CAGR 7% 2021-2027. Immune repertoire sequencing is used extensively for biomarker discovery to improve the success rate and cost-effectiveness of rational drug development. For example, in November 2017, the Center for Commercialization of […]
